文献速递生殖医学

体质指数对早卵泡期长效长方案IVF/ICSI新鲜周期胚胎移植结局的影响

[Impact of BMI on fresh cycle embryo transfer outcome of IVF/ICSI in patients with early follicular phase prolonged protocol].
PubMed 文献 · Zhonghua Fu Chan Ke Za Zhi · 2021-01-01

回顾性分析2018年1月1日至2020年7月1日南京医科大学第一附属医院2257例早卵泡期长效长方案IVF/ICSI患者,按BMI分为低BMI组141例、正常BMI组1663例、超重肥胖组453例;超重肥胖组促性腺激素启动剂量、总剂量最多且用药天数最长,获卵数较正常BMI组减少,但1741例新鲜胚胎移植中三组妊娠结局无统计学差异。

要点

  • 超重肥胖组促性腺激素总剂量(2159±668)U最多、用药天数(12.3±2.5)d最长(P均<0.01)。
  • 超重肥胖组hCG日雌二醇(7474±4852)pmol/L、孕酮(3.4±1.9)nmol/L均低于低BMI组及正常BMI组(P均<0.01)。
  • 新鲜胚胎移植三组生化妊娠率、临床妊娠率、活产率差异均无统计学意义(P均>0.05)。

核心结论

  • BMI升高可能影响早卵泡期长效长方案IVF/ICSI患者的诱导排卵反应,导致促性腺激素用量增加及诱导排卵时间延长。
  • 不同BMI组新鲜周期胚胎移植妊娠结局无统计学差异,但考虑超重肥胖患者后续妊娠围产期不良风险增高,临床工作中仍应重视控制BMI。

研究设计与样本

  • 回顾性分析2018年1月1日至2020年7月1日于南京医科大学第一附属医院首次行早卵泡期长效长方案IVF/ICSI治疗患者的临床资料,共2257例。
  • 按BMI分为低BMI组(BMI<18.5 kg/m2,141例)、正常BMI组(18.5≤BMI<24.0 kg/m2,1663例)、超重肥胖组(BMI≥24.0 kg/m2,453例)。
  • 从中筛选新鲜胚胎移植患者1741例,分为低BMI新鲜组(102例)、正常BMI新鲜组(1266例)、超重肥胖新鲜组(373例)。

主要发现

  • 三组促性腺激素启动剂量、总天数、总剂量均有显著差异(P均<0.01);超重肥胖组启动剂量(162±40)U、总剂量(2159±668)U最多,总天数(12.3±2.5)d最长。
  • 超重肥胖组hCG日雌二醇(7474±4852)pmol/L及孕酮(3.4±1.9)nmol/L均显著低于低BMI组及正常BMI组(P均<0.01)。
  • 超重肥胖组获卵数(8.4±4.1)个较正常BMI组减少(P<0.05)。
  • 超重肥胖组正常受精数、可移植胚胎数、高评分卵裂期胚胎数均较其他两组略减少,但差异均无统计学意义(P均>0.05)。
  • 1741例新鲜胚胎移植中,低BMI新鲜组移植胚胎数(1.2±0.4)个较其他两组减少(P<0.05);正常BMI新鲜组生化妊娠率、临床妊娠率、活产率较其他两组增高,但差异均无统计学意义(P均>0.05)。

临床怎么用

  • 作者认为,临床工作中对于行早卵泡期长效长方案治疗的患者仍应重视控制BMI。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the impact of body mass index (BMI) on clinical effect and fresh cycle embryo transfer pregnancy outcome of in vitro fertilization or intracytoplasmic sperm injection (IVF/ICSI) in patients with early follicular phase prolonged protocol. Methods: From January 1st, 2018 to July 1st, 2020, 2 257 cases of early follicular long-term protocol in IVF/ICSI and embryo transfer were collected using the clinical assisted reproductive technologies management system software database of the First Affiliated Hospital of Nanjing Medical University. Patients were divided into three groups according to the recommended Asian BMI cut-off points: low body mass group (BMI<18.5 kg/m2), normal body mass group (18.5≤BMI<24.0 kg/m2), and high body mass group (BMI≥24.0 kg/m2). The ovarian stimulation characteristics among the groups were investigated. Then 1 741 fresh embryo transfer cycles were selected and divided into three groups as above, and then the ovulation induction and clinical outcomes were analyzed among the groups. Results: There were significant differences in the starting dosage of gonadotrophin (Gn), total dosage of Gn and days of Gn used among the low body mass group, normal body mass group, and high body mass group in the 2 257 IVF/ICSI cycles (all P<0.01). The high body mass group needed the most amount of Gn [(2 159±668) U] and longest Gn days [(12.3±2.5) days]. The estradiol and progesterone levels [(7 474±4 852) pmol/L, (3.4±1.9) nmol/L] on hCG trigger day in the high body mass group were lower than those in the low body mass group and normal body mass group (all P<0.01). The oocytes retrieved in high body mass group (8.4±4.1) were significantly lower than normal body mass group (P<0.05). The normal fertilization number, the available embryo number and high quality embryo number were all lower in the high body mass group than other two groups, while no significant difference showed (all P>0.05). In 1 741 cycles of fresh embryo transfer, the average number of transplanted embryos in the low body mass group (1.2±0.4) was decreased compared with the other two groups (P<0.05), while the biochemical pregnancy rate, clinical pregnancy rate and live birth rate in the normal body mass group were higher compared with the other two groups, but the differences showed no statistically significance (all P>0.05). Conclusions: Increased BMI might affect ovulation induction response in early follicular phase prolonged protocol IVF/ICSI patients, leading to the increase of Gn dosage and the extension of Gn induction days. Although there is no significant difference in pregnancy outcome among different BMI groups, considering the increased risk of adverse perinatal outcomes during subsequent pregnancy in overweight or obese patients, certain attention should still be paid to the control of BMI in patients receiving assisted reproduction treatment with early follicular phase prolonged protocol. 目的: 探究体质指数(BMI)对于进行早卵泡期长效长方案体外受精或卵母细胞胞质内单精子注射法(IVF/ICSI)治疗患者的治疗过程以及新鲜周期胚胎移植妊娠结局的影响。 方法: 回顾性分析2018年1月1日至2020年7月1日于南京医科大学第一附属医院首次行早卵泡期长效长方案的IVF/ICSI治疗患者的临床资料。按照患者的BMI分为低BMI组(BMI<18.5 kg/m2,141例)、正常BMI组(18.5≤BMI<24.0 kg/m2,1 663例)、超重肥胖组(BMI≥24.0 kg/m2,453例),分析各组患者的诱导排卵指标有无差异;再从3组中筛选出进行新鲜胚胎移植的患者分别命名为低BMI新鲜组(102例)、正常BMI新鲜组(1 266例)、超重肥胖新鲜组(373例),比较各组的诱导排卵情况和妊娠结局。 结果: 本研究共纳入2 257例患者,低BMI组、正常BMI组及超重肥胖组患者的促性腺激素(Gn)启动剂量、Gn总天数、Gn总剂量均有显著差异(P均<0.01),超重肥胖组Gn启动剂量[(162±40)U]、Gn总剂量[(2 159±668)U]均最多、Gn总天数[(12.3±2.5)d]最长。超重肥胖组hCG日雌二醇及孕酮水平[分别为(7 474±4 852)pmol/L、(3.4±1.9)nmol/L]均显著低于低BMI组及正常BMI组(P均<0.01),获卵数[(8.4±4.1)个]较正常BMI组减少(P<0.05)。超重肥胖组患者的正常受精数、可移植胚胎数、高评分卵裂期胚胎数均较其他2组略减少,但差异均无统计学意义(P均>0.05)。进行新鲜胚胎移植的1 741例患者中,低BMI新鲜组的移植胚胎数[(1.2±0.4)个]较其他2组减少(P<0.05),正常BMI新鲜组患者的生化妊娠率、临床妊娠率、活产率较其他2组增高,但差异均无统计学意义(P均>0.05)。 结论: 在进行早卵泡期长方案lVF/ICSI治疗的患者中,BMI升高可能会影响诱导排卵反应,导致Gn用量增加、Gn诱导排卵的时间延长。虽然不同BMI的各组新鲜周期胚胎移植的妊娠结局尚无统计学差异,但考虑超重、肥胖患者后续妊娠后围产期不良风险增高,故临床工作中对于行早卵泡期长方案治疗的患者仍应重视控制BMI。.

来源:Zhonghua Fu Chan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Qian Y, Zhang J, Jiang CY, et al. [Impact of BMI on fresh cycle embryo transfer outcome of IVF/ICSI in patients with early follicular phase prolonged protocol]. Zhonghua Fu Chan Ke Za Zhi. 2021. PMID: 34954966. doi:10.3760/cma.j.cn112141-20210831-00477

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。